The neurological and oncological associations in particular rest on small studies and should be read as hypotheses rather than findings
Topical Dosing Protocols GHK-Cu topical formulations have been studied in clinical trials for over two decades, making this the most evidence-supported delivery route
Additionally, BPC-157 has been associated with increased growth hormone receptor expression in tendon fibroblasts, suggesting it may enhance the body's responsiveness to growth hormone at the tissue level
In preclinical work, BPC-157 has been evaluated in cell-based and animal models, in which investigators examine tissue integrity, barrier function, and responses to experimentally induced stress or injury under controlled conditions
Phase 3 trials have now initiated for overweight and obesity at this point, assessing CagriSema in larger numbers and for longer periods of time. References: Frias JP, et al
The spray format offers ease of use and may facilitate rapid absorption